Novartis to Split Drug Business to focus on AntiCancer Drugs

Novartis is looking out for splitting the Drug Business in to two sections. Out of which one section will be looking after Anti-cancaer Drugs while other drugs will be focused by another division

The division shows the growing importance of Oncology section to company.

“Novartis expects this change to help drive our growth and innovation strategy, with an increased focus and improved execution,” the company said in a statement.

The logo of Swiss drugmaker Novartis is seen at its headquarters in Basel, Switzerland October 22, 2013. REUTERS/Arnd Wiegmann/File Photo




Team Pharmacy Infoline
Facebooktwittergoogle_plusredditpinterestlinkedinmail

Admin

Team Pharmacy Infoline

Leave a Reply

Your email address will not be published. Required fields are marked *